摘要
Objective To assess the efficacy and safety of methotrexate(MTX)on refractory Crohn’s disease(CD).Methods A total of 35 consecutive refractory CD patients in the First Affiliated Hospital of Sun Yat-Sen University treated with MTX were retrospectively analyzed.Clinical data from June 2004 to December 2012 were collected from the database of inflammatory bowel disease(IBD)center.Clinical responses and drug side effects were recorded and analyzed.Results Thirty-five refractory
